2023 annual financial data
Polaryx Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -3,781,000 USD and net income was -3,779,000 USD.
Operating cash flow was -173,000 USD.
Get free Polaryx Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,781,000 USD
- Net income
- -3,779,000 USD
- Operating cash flow
- -173,000 USD